zoom_in Click to enlarge

Gertrude Elion

▲ ▼

description Gertrude Elion Overview

Gertrude Elion was a pioneering American biochemist whose work revolutionized medicine. Utilizing rational drug design – a method of targeting specific biochemical pathways – she developed numerous effective therapeutic drugs. Her innovative approach, bypassing traditional trial-and-error methods, earned her the 1988 Nobel Prize in Physiology or Medicine. Elion’s research significantly impacted pharmacology and remains crucial for scientists and physicians involved in drug development and treatment of diseases.

help Gertrude Elion FAQ

What specific drugs did Gertrude Elion develop?

Elion developed several major medications while at Burroughs Wellcome, including 6-mercaptopurine (6-MP) for childhood leukemia, azathioprine (Imuran) to prevent organ transplant rejection, and acyclovir (Zovirax) for herpes infections. She also contributed to the development of allopurinol for gout and pyrimethamine for malaria.

How did Gertrude Elion's rational drug design differ from traditional drug discovery?

Instead of the traditional trial-and-error approach of testing thousands of random compounds, Elion and George Hitchings designed drugs by targeting specific biochemical pathways in diseased cells. By selectively blocking purine metabolism, they could kill cancer cells or parasites while sparing healthy tissue.

Did Gertrude Elion have a PhD when she won the Nobel Prize?

No, Elion never completed a formal doctorate degree. She was rejected from graduate programs in the 1930s partly because of gender discrimination, yet went on to win the 1988 Nobel Prize in Physiology or Medicine shared with George Hitchings and Sir James Black.

Was Gertrude Elion the first woman inducted into the National Inventors Hall of Fame?

Yes, Elion became the first woman inducted into the National Inventors Hall of Fame in 1991. She held 45 patents related to drug compounds and was also elected to the National Academy of Sciences in 1990.